المؤلفون: G Palmieri, F Consoli, M Valente, Corrado Caracò, Paolo Antonio Ascierto, Michele Maio, M Guida, G Rinaldi, Angelo Paolo Dei Tos, R Berardi, Giovanni Grignani, Paola Queirolo, Francesca Spada, Nicola Fazio, A Córdova, L Repetto, B Vincenzi, D Massi, G Fabbrocini, A Berruti, L Tagliaferri, P Rubegni, P Poletti, M Barberis, F Picciotto, Paolo Bossi, M Gatti, Vanna Chiarion Sileni, Pietro Quaglino, GC Antonini Cappellini, L Antonuzzo, G Badalamenti, F Bassetto, A Bongiovanni, P Bonomo, L Borgognoni, V Borzillo, F Bruder, D Campana, R Depenni, AM Di Giacomo, MC Fargnoli, V Ferraresi, F Ferrau, MT Fierro, F Gelsomino, D Giuffrida, P Graziano, C Gregorelli, R Mazzarotto, L Milesi, AM Minisini, F Morgese, P Muto, R Patuzzo, G Pellacani, J Pigozzo, N Pimpinelli, G Rubino, F Spagnolo, E Tanda, MC Tronconi, M Tucci, I Zalaudek

المصدر: Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://jitc.bmj.com/content/10/6/e004742.full; https://doaj.org/toc/2051-1426

URL الوصول: https://doaj.org/article/803650a72e7f4b7aa71f13ef3550f03b

المؤلفون: SK. Garattini, F. Valent, AM. Minisini, C. Riosa, C. Favaretti, L. Regattin, G. Fasola

المصدر: BMC Health Services Research, Vol 22, Iss 1, Pp 1-8 (2022)

مصطلحات موضوعية: Oncology workload, Oncology workforce, Oncology planning, Sustainability, Public aspects of medicine, RA1-1270

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1472-6963

URL الوصول: https://doaj.org/article/fec12855c3554ce69b32314ce6d0d28f

المؤلفون: Silvio Garattini, F Valent, AM Minisini, C Riosa, C Favaretti, L Regattin, G Fasola

المصدر: BMC Health Services Research. 22

مصطلحات موضوعية: Neoplasms, Health Policy, Humans, Workload, Medical Oncology, Referral and Consultation, Retrospective Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e278a11712caad4af4309e547170cf8b
https://doi.org/10.1186/s12913-022-08573-3

المؤلفون: Migliaccio I; Translational Research Unit, Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Romagnoli D; Bioinformatics Unit, Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Galardi F; Translational Research Unit, Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., De Luca F; Translational Research Unit, Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Biagioni C; Bioinformatics Unit, Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Curigliano G; Division of Early Drug Development, Istituto Europeo di Oncologia, IRCCS, Milano, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Criscitiello C; Division of Early Drug Development, Istituto Europeo di Oncologia, IRCCS, Milano, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Minisini AM; Department of Oncology, Azienda Sanitaria Universitaria Integrata del Friuli Centrale, Udine, Italy., Moretti E; Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Risi E; Translational Research Unit, Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy.; Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Guarducci C; Translational Research Unit, Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Nardone A; Translational Research Unit, Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Biganzoli L; Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Benelli M; Bioinformatics Unit, Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Malorni L; Translational Research Unit, Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy.; Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy.

المصدر: JCO precision oncology [JCO Precis Oncol] 2024 Feb; Vol. 8, pp. e2300285.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Circulating Tumor DNA*/genetics , Piperazines* , Pyridines* , Receptor, ErbB-2*, Humans ; Female ; Phosphatidylinositol 3-Kinases ; Receptors, Estrogen/genetics

المؤلفون: Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics. I.N.T. IRCCS Fondazione 'G. Pascale', Napoli, Italy. p.ascierto@istitutotumori.na.it., Casula M; Immuno-Oncology & Targeted Cancer Biotherapies, University of Sassari - Unit of Cancer Genetics, IRGB-CNR, 07100, Sassari, Italy., Bulgarelli J; Immunotherapy, Cell Therapy Unit and Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Pisano M; Immuno-Oncology & Targeted Cancer Biotherapies, University of Sassari - Unit of Cancer Genetics, IRGB-CNR, 07100, Sassari, Italy., Piccinini C; Immunotherapy, Cell Therapy Unit and Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Piccin L; Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Cossu A; Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy., Mandalà M; University of Perugia, Perugia, Italy.; Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy., Ferrucci PF; Biotherapy of Tumors Unit, Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan, Italy., Guidoboni M; Immunotherapy, Cell Therapy Unit and Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska Curie National Research Institute of Oncology, 02-781 -, Warsaw, Poland., Ferraresi V; Department of Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Arance A; Department of Medical Oncology, Hospital Clínic Barcelona, 08036, Barcelona, Spain., Guida M; Rare Tumors and Melanoma Unit, IRCCS Istituto dei Tumori 'Giovanni Paolo II', Bari, Italy., Maiello E; Oncology Unit, Foundation IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Gogas H; First Department of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Richtig E; Department of Dermatology, Medical University of Graz, Graz, Austria., Fierro MT; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy., Lebbe C; Dermato-Oncology and CIC AP-HP Hôpital Saint Louis,Cancer Institute APHP. Nord-Université Paris Cite F-75010, Paris, INSERM U976, France., Helgadottir H; Department of Oncology-Pathology, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden., Queirolo P; Skin Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Division of melanoma Sarcoma and Rare Tumors, IRCCS European Institute of Oncology, Milan, Italy., Spagnolo F; Skin Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Tucci M; Department of Interdisciplinary Medicine, Oncology Unit, University of Bari 'Aldo Moro', Bari, Italy., Del Vecchio M; Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cao MG; Department of Medical Oncology, University Hospital Dexeus, Barcelona, Spain., Minisini AM; Academic Hospital 'Santa Maria della Misericordia', Udine, Italy., De Placido S; Department of Clinical Medicine and Surgery, University of Naples 'Federico II', Naples, Italy., Sanmamed MF; Department of Interdisciplinary Medicine, Oncology Unit, University of Bari 'Aldo Moro', Bari, Italy., Mallardo D; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics. I.N.T. IRCCS Fondazione 'G. Pascale', Napoli, Italy., Paone M; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics. I.N.T. IRCCS Fondazione 'G. Pascale', Napoli, Italy., Vitale MG; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics. I.N.T. IRCCS Fondazione 'G. Pascale', Napoli, Italy., Melero I; Department of Immunology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain., Grimaldi AM; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics. I.N.T. IRCCS Fondazione 'G. Pascale', Napoli, Italy.; Medical Oncology Unit, AORN San Pio, Benevento, Italy., Giannarelli D; Fondazione Policlinico Universitario A. Gemelli, IRCCS - Facility of Epidemiology and Biostatistics, Rome, Italy., Dummer R; Department of Dermatology, University and University Hospital Zurich, Zurich, Switzerland., Sileni VC; Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Palmieri G; Immuno-Oncology & Targeted Cancer Biotherapies, University of Sassari - Unit of Cancer Genetics, IRGB-CNR, 07100, Sassari, Italy.

المصدر: Nature communications [Nat Commun] 2024 Jan 02; Vol. 15 (1), pp. 146. Date of Electronic Publication: 2024 Jan 02.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/drug therapy , Melanoma*/genetics , Skin Neoplasms*/genetics, Humans ; Proto-Oncogene Proteins B-raf/genetics ; Ipilimumab/therapeutic use ; Immunotherapy/methods ; Protein Kinase Inhibitors/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Mitogen-Activated Protein Kinase Kinases/genetics ; Mutation

المؤلفون: Pelizzari G; Department of Oncology, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC)., Bertoli E; Department of Medicine (DAME), University of Udine, Udine.; Department of Medical Oncology, CRO Aviano National Cancer Institute IRCSS, Aviano., Buriolla S; Department of Oncology, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC).; Department of Medicine (DAME), University of Udine, Udine., Vitale MG; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli., Basile D; Department of Medical Oncology, San Giovanni di Dio Hospital, Crotone, Italy., Palmero L; Department of Medicine (DAME), University of Udine, Udine.; Department of Medical Oncology, CRO Aviano National Cancer Institute IRCSS, Aviano., Zara D; Department of Medicine (DAME), University of Udine, Udine.; Department of Medical Oncology, CRO Aviano National Cancer Institute IRCSS, Aviano., Iacono D; Department of Oncology, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC)., Andrea F; Department of Medical Oncology, CRO Aviano National Cancer Institute IRCSS, Aviano., Pascoletti G; Department of Oncology, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC)., Bolzonello S; Department of Medical Oncology, CRO Aviano National Cancer Institute IRCSS, Aviano., Garutti M; Department of Medical Oncology, CRO Aviano National Cancer Institute IRCSS, Aviano., Fasola G; Department of Oncology, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC)., Puglisi F; Department of Medicine (DAME), University of Udine, Udine.; Department of Medical Oncology, CRO Aviano National Cancer Institute IRCSS, Aviano., Minisini AM; Department of Oncology, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC).

المصدر: Melanoma research [Melanoma Res] 2023 Oct 01; Vol. 33 (5), pp. 398-405. Date of Electronic Publication: 2023 Jul 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9109623 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5636 (Electronic) Linking ISSN: 09608931 NLM ISO Abbreviation: Melanoma Res Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/pathology , Skin Neoplasms*/surgery , Brain Neoplasms*/secondary , Radiosurgery*, Humans ; Prognosis ; Retrospective Studies ; L-Lactate Dehydrogenase

المؤلفون: Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione 'G. Pascale' Napoli, Naples, Italy., Mandalà M; Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy.; University of Perugia, Perugia, Italy., Ferrucci PF; Biotherapy of Tumors Unit, Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan, Italy., Guidoboni M; Immunotherapy and Cell Therapy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska Curie National Research Institute of Oncology, Warsaw, Poland., Ferraresi V; Department of Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Arance A; Department of Medical Oncology, Hospital Clínic Barcelona, Barcelona, Spain., Guida M; Rare Tumors and Melanoma Unit, IRCCS Istituto dei Tumori 'Giovanni Paolo II,' Bari, Italy., Maiello E; Oncology Unit, Foundation IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy., Gogas H; First Department of Medicine, National and Kapodistrian University of Athens, Zografou, Greece., Richtig E; Department of Dermatology, Medical University of Graz, Graz, Austria., Fierro MT; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy., Lebbè C; Department of Oncology-Pathology, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden., Helgadottir H; Immunotherapy and Cell Therapy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Queirolo P; IRCCS Ospedale Policlinico San Martino, Skin Cancer Unit, Genova, Italy.; Division of Melanoma Sarcoma and Rare Tumors, IRCCS European Institute of Oncology, Milan, Italy., Spagnolo F; IRCCS Ospedale Policlinico San Martino, Skin Cancer Unit, Genova, Italy., Tucci M; Department of Interdisciplinary Medicine, Oncology Unit, University of Bari 'Aldo Moro,' Bari, Italy., Del Vecchio M; Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gonzales Cao M; Department of Medical Oncology, University Hospital Dexeus, Barcelona, Spain., Minisini AM; Academic Hospital 'Santa Maria della Misericordia,' Udine, Italy., De Placido S; Department of Clinical Medicine and Surgery, University of Naples 'Federico II,' Naples, Italy., Sanmamed MF; Department of Immunology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain., Mallardo D; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione 'G. Pascale' Napoli, Naples, Italy., Curvietto M; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione 'G. Pascale' Napoli, Naples, Italy., Melero I; Department of Immunology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain., Palmieri G; Immuno-Oncology & Targeted Cancer Biotherapies, University of Sassari, Unit of Cancer Genetics, IRGB-CNR, Sassari, Italy., Grimaldi AM; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione 'G. Pascale' Napoli, Naples, Italy.; Medical Oncology Unit, AORN San Pio Benevento, Benevento, Italy., Giannarelli D; Regina Elena National Cancer Institute, IRCCS-Biostatistical Unit, Rome, Italy., Dummer R; Department of Dermatology, University and University Hospital Zurich, Zurich, Switzerland., Chiarion Sileni V; Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jan 10; Vol. 41 (2), pp. 212-221. Date of Electronic Publication: 2022 Sep 01.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Melanoma*/genetics , Melanoma*/therapy , Nivolumab*/therapeutic use , Proto-Oncogene Proteins B-raf*/genetics , Immunotherapy*/methods , Skin Neoplasms*/genetics , Skin Neoplasms*/therapy, Humans ; Ipilimumab ; Prospective Studies

المؤلفون: Albanell J; Medical Oncology Department, Hospital del Mar, Barcelona, Spain.; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain.; Universitat Pompeu Fabra, Barcelona, Spain.; GEICAM, Spain., Pérez-García JM; International Breast Cancer Center (IBCC), Quironsalud Group, Barcelona, Spain.; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey., Gil-Gil M; GEICAM, Spain.; Catalan Institute of Oncology, Breast Cancer Unit, Medical Oncology Department, IDIBELL, Barcelona, Spain., Curigliano G; Istituto Europeo di Oncologia, IRCCS, Milano, Italy.; University of Milano, Department of Oncology and Hemato-Oncology, Milano, Italy., Ruíz-Borrego M; GEICAM, Spain.; Hospital Universitario Virgen del Rocío, Sevilla, Spain., Comerma L; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Pathology Department, Hospital del Mar, Barcelona, Spain., Gibert J; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Pathology Department, Hospital del Mar, Barcelona, Spain., Bellet M; Vall d´Hebrón University Hospital, Barcelona, Spain.; Vall d´Hebrón Institute of Oncology (VHIO), Barcelona, Spain., Bermejo B; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain.; GEICAM, Spain.; Medical Oncology, Hospital Clínico Universitario de Valencia, Biomedical Research Institute INCLIVA, Valencia; Medicine Department, Universidad de Valencia, Valencia, Spain., Calvo L; GEICAM, Spain.; Complejo Hospitalario Universitario A Coruña (CHUAC), La Coruña, Spain., de la Haba J; Hospital Universitario Reina Sofía, Córdoba, Spain., Espinosa E; Hospital Universitario La Paz, Madrid, Spain., Minisini AM; Department of Oncology, Azienda Sanitaria Universitaria del Friuli Centrale, Udine, Italy., Quiroga V; Badalona-Applied Research Group in Oncology (B-ARGO Group), Catalan Institute of Oncology, Badalona, Barcelona, Spain., Santaballa Bertran A; Hospital Universitari i Politècnic La Fe, Valencia, Spain., Mina L; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey., Bellosillo B; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain.; Universitat Pompeu Fabra, Barcelona, Spain.; Pathology Department, Hospital del Mar, Barcelona, Spain., Rojo F; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain.; GEICAM, Spain.; IIS-Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Menéndez S; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain., Sampayo-Cordero M; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey., Popa C; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey., Malfettone A; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey., Cortés J; International Breast Cancer Center (IBCC), Quironsalud Group, Barcelona, Spain.; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey.; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain., Llombart-Cussac A; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey.; Hospital Arnau de Vilanova, Valencia, Spain.; Universidad Catolica, Valencia, Spain.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jan 04; Vol. 29 (1), pp. 67-80.

نوع المنشور: Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology, Female ; Humans ; Piperazines/therapeutic use

المؤلفون: Targato G; Department of Medicine (DAME), University of Udine, 33100 Udine, Italy.; Department of Oncology, Udine Academic Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), 33100 Udine, Italy., Bortot L; Department of Medicine (DAME), University of Udine, 33100 Udine, Italy.; Department of Oncology, Udine Academic Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), 33100 Udine, Italy., Dri A; Department of Medicine (DAME), University of Udine, 33100 Udine, Italy.; Department of Oncology, Udine Academic Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), 33100 Udine, Italy., Bonotto M; Department of Oncology, Udine Academic Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), 33100 Udine, Italy., Minisini AM; Department of Oncology, Udine Academic Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), 33100 Udine, Italy., Fasola G; Department of Oncology, Udine Academic Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), 33100 Udine, Italy., Mansutti M; Department of Oncology, Udine Academic Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), 33100 Udine, Italy.

المصدر: Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Dec 06; Vol. 29 (12), pp. 9630-9639. Date of Electronic Publication: 2022 Dec 06.

نوع المنشور: Review; Case Reports

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology, Female ; Humans ; Aged ; Protein Kinase Inhibitors/pharmacology ; Molecular Targeted Therapy ; Cyclin-Dependent Kinase 4

المؤلفون: Garattini SK; Department of Oncology, Academic Hospital of Udine ASUFC, Piazzale Santa Maria della Misericordia 15, Udine, UD, 33100, Italy. silvioken.garattini@asufc.sanita.fvg.it., Valent F; Institute of Hygiene and Clinical Epidemiology, Academic Hospital of Udine ASUFC, 33100, Udine, UD, Italy., Minisini AM; Department of Oncology, Academic Hospital of Udine ASUFC, Piazzale Santa Maria della Misericordia 15, Udine, UD, 33100, Italy., Riosa C; Department of Oncology, Academic Hospital of Udine ASUFC, Piazzale Santa Maria della Misericordia 15, Udine, UD, 33100, Italy., Favaretti C; Center for Leadership in Medicine, Catholic University of Sacred Heart, 000168, Rome, RO, Italy., Regattin L; Medical Director, Academic Hospital of Udine ASUFC, Piazzale Santa Maria della Misericordia 15, Udine, UD, 33100, Italy., Fasola G; Department of Oncology, Academic Hospital of Udine ASUFC, Piazzale Santa Maria della Misericordia 15, Udine, UD, 33100, Italy.

المصدر: BMC health services research [BMC Health Serv Res] 2022 Sep 21; Vol. 22 (1), pp. 1184. Date of Electronic Publication: 2022 Sep 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963 (Electronic) Linking ISSN: 14726963 NLM ISO Abbreviation: BMC Health Serv Res Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/therapy , Workload*, Humans ; Medical Oncology ; Referral and Consultation ; Retrospective Studies